Rare diseases
Investigational molecules
Locations
Back to Poland44 clinical trials in Piotrkow Trybunalski, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
PolandStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
PolandStudy of Sasanlimab with BCG or Alone for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Not Responding to BCG
PolandStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
PolandA study to evaluate the efficacy and safety of vixarelimab in patients with moderate to severe ulcerative colitis
PolandEfficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PolandComparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control
PolandStudy of orforglipron in people with high blood pressure who are overweight or have obesity
PolandStudy on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment
PolandStudy of INBRX-106 and Pembrolizumab for First-Line Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer
PolandStudy on the Effects of Etrasimod Arginine for Patients with Moderate to Severe Crohn's Disease
PolandStudy on JTT-861 for Patients with Heart Failure with Reduced Ejection Fraction
PolandThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on innovative treatments for bladder cancer, including combinations with immunotherapy agents and novel therapeutic approaches for head and neck cancer. Multiple trials are evaluating new combination therapies for prostate cancer.
Research emphasizes improving survival rates and treatment outcomes through targeted therapies.
Comprehensive research into heart failure treatments, particularly focusing on reduced ejection fraction conditions. Studies evaluate new medications for stroke prevention in patients with atrial fibrillation.
Trials aim to improve patient outcomes and develop more effective treatment options.
Innovative research targeting multiple sclerosis, rheumatoid arthritis, and Sjögren's syndrome. Studies evaluate novel therapeutic approaches and biosimilar medications.
Focus on developing targeted treatments to improve disease management and patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
